ProMetic and American Red Cross form joint venture:
This article was originally published in Clinica
Montreal, Canada-based ProMetic Life Sciences and the American Red Cross (ARC) have formed a joint venture company. The new company will be aimed at researching, developing and commercialising diagnostic and removal systems for and other pathogens that may cause transmissible spongiform encephalopathies (TSEs) and certain viruses. ProMetic and ARC will each contribute intellectual property and technical expertise.